An update on synthetic high-density lipoprotein-like nanoparticles for cancer therapy

References

• Barter P. The role of HDL-cholesterol in preventing atherosclerotic disease. Eur Heart J Suppl. 2005 Jul;7(F):F4–F8. PubMed PMID: WOS:000230780800003; English. .
   Web of Science ®Google Scholar
• Mendivil CO, Furtado J, Morton AM, et al. Novel pathways of apolipoprotein A-I metabolism in high-density lipoprotein of different sizes in humans. Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):156–165. PubMed PMID: 26543096; PubMed Central PMCID: PMCPMC4690755.
   PubMed Web of Science ®Google Scholar
• Sacks FM, Jensen MK. From high-density lipoprotein cholesterol to measurements of function: prospects for the development of tests for high-density lipoprotein functionality in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):487–499. PubMed PMID: 29371248; PubMed Central PMCID: PMCPMC5823773. .
   PubMed Web of Science ®Google Scholar
• Li JJ, Zhang Y, Li S, et al. Large HDL subfraction but not HDL-C is closely linked with risk factors, coronary severity and outcomes in a cohort of nontreated patients with stable coronary artery disease a prospective observational study. Medicine (Baltimore). 2016 Jan;95(4):ARTN e2600. PubMed PMID: WOS:000370535800001; English.
   Web of Science ®Google Scholar
• Pirro M, Ricciuti B, Rader DJ, et al. High density lipoprotein cholesterol and cancer: marker or causative? Prog Lipid Res. 2018 Jul;71:54–69. PubMed PMID: 29879431.
   PubMed Web of Science ®Google Scholar
• Jafri H, Alsheikh-Ali AA, Karas RH. Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol. 2010 Jun 22;55(25):2846–2854. PubMed PMID: 20579542.
   PubMed Web of Science ®Google Scholar
• Yang C, Tian G, Mi J, et al. Causal relevance of circulating high-density lipoprotein cholesterol with cancer: a Mendelian randomization meta-analysis. Sci Rep. 2015 Mar 30; 5:9495. PubMed PMID: 25820350; PubMed Central PMCID: PMCPMC4377635.
   PubMed Web of Science ®Google Scholar
• Scribano D, Baroni S, Pagano L, et al. Return to normal values of lipid pattern after effective chemotherapy in acute lymphoblastic leukemia. Haematologica. 1996 Jul;81(4):343–345. Aug. PubMed PMID: WOS:A1996VF36000010; English
   PubMed Web of Science ®Google Scholar
• Kuzu OF, Noory MA, Robertson GP. The role of cholesterol in cancer. Cancer Res. 2016 Apr 15;76(8):2063–2070. PubMed PMID: 27197250; PubMed Central PMCID: PMCPMC5813477.
   PubMed Web of Science ®Google Scholar
• Brouillette CG, Anantharamaiah GM, Engler JA, et al. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta. 2001 Mar 30;1531(1–2):4–46. PubMed PMID: 11278170
   PubMed Web of Science ®Google Scholar
• Silva RA, Huang R, Morris J, et al. Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12176–12181. PubMed PMID: 18719128; PubMed Central PMCID: PMCPMC2527885.
   PubMed Web of Science ®Google Scholar
• Rothblat GH, Phillips MC. High-density lipoprotein heterogeneity and function in reverse cholesterol transport. Curr Opin Lipidol. 2010 Jun;21(3):229–238. PubMed PMID: 20480549; PubMed Central PMCID: PMCPMC3215082
   PubMed Web of Science ®Google Scholar
• Heinecke JW. The HDL proteome: a marker-and perhaps mediator-of coronary artery disease. J Lipid Res. 2009 Apr;50:S167–S171. PubMed PMID: WOS:000265128400029; English.
   PubMed Web of Science ®Google Scholar
• Eroglu M, Yilmaz N, Yalcinkaya S, et al. Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients. Kaohsiung J Med Sci. 2013 Jul;29(7):368–373. PubMed PMID: 23768700.
   PubMed Web of Science ®Google Scholar
• Rosenblat M, Vaya J, Shih D, et al. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Atherosclerosis. 2005 Mar;179(1):69–77. PubMed PMID: WOS:000227571700008; English.
   PubMed Web of Science ®Google Scholar
• Kurano M, Yatomi Y. Sphingosine 1-Phosphate and Atherosclerosis. J Atheroscler Thromb. 2018;25(1):16–26. PubMed PMID: WOS:000424513200002; English. .
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011 Mar 20;13:423–433. en.
   PubMed Web of Science ®Google Scholar
• Lund-Katz S, Phillips MC. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell Biochem. 2010;51:183–227. PubMed PMID: 20213545; PubMed Central PMCID: PMCPMC3215094.
   PubMedGoogle Scholar
• Lv Y, Miao LY, Chen QF, et al. Monitoring of high-density lipoprotein cholesterol level is predictive of EGFR mutation and efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma. Oncol Targets Ther. 2016;9:461–468. PubMed PMID: WOS:000368535100002; English.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Cao W, Jin H, et al. Biomimetic nanocarrier for direct cytosolic drug delivery. Angew Chem Int Ed Engl. 2009;48(48):9171–9175. PubMed PMID: 19876988.
   PubMed Web of Science ®Google Scholar
• Lim U, Gayles T, Katki HA, et al. Serum high-density lipoprotein cholesterol and risk of non-hodgkin lymphoma. Cancer Res. 2007 Jun 1;67(11):5569–5574. PubMed PMID: 17522388.
   PubMed Web of Science ®Google Scholar
• Kucharska-Newton AM, Rosamond WD, Mink PJ, et al. HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol. 2008 Sep;18(9):671–677. PubMed PMID: 18794007; PubMed Central PMCID: PMCPMC2566531.
   PubMed Web of Science ®Google Scholar
• Furberg AS, Veierod MB, Wilsgaard T, et al. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 2004 Aug 4;96(15):1152–1160. PubMed PMID: 15292387.
   PubMedGoogle Scholar
• Penson P, Long DL, Howard G, et al. Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study. Cardiovasc Res. 2019 Jan 1;115(1):204–212. PubMed PMID: 30576432; PubMed Central PMCID: PMCPMC6302258.
   PubMed Web of Science ®Google Scholar
• Cooper RA. Influence of increased membrane cholesterol on membrane fluidity and cell-function in human red blood-cells. J Supramol Str Cell. 1978 PubMed PMID: WOS:A1978FW42700003; English;8(4):413–430.
   Google Scholar
• Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest. 2002 Sep;110(5):597–603. PubMed PMID: 12208858; PubMed Central PMCID: PMCPMC151114.
   PubMed Web of Science ®Google Scholar
• Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res. 2011 Jan;52(1):6–34. PubMed PMID: 20929975; PubMed Central PMCID: PMCPMC2999931. .
   PubMed Web of Science ®Google Scholar
• Rudney H, Sexton RC. Regulation of cholesterol-biosynthesis. Annu Rev Nutr. 1986;6:245–272. PubMed PMID: WOS:A1986D346300012; English
   PubMed Web of Science ®Google Scholar
• Gutierrez-Pajares JL, Ben Hassen C, Chevalier S, et al. SR-BI: linking cholesterol and lipoprotein metabolism with breast and prostate cancer. Front Pharmacol. 2016;7:338. PubMed PMID: 27774064; PubMed Central PMCID: PMCPMC5054001.
   PubMed Web of Science ®Google Scholar
• Rink JS, Yang S, Cen O, et al. Rational targeting of cellular cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) enabled by functional lipoprotein nanoparticles: a therapeutic strategy dependent on cell of origin. Mol Pharm. 2017 Nov 6;14(11):4042–4051. PubMed PMID: 28933554; PubMed Central PMCID: PMCPMC6004607.
   PubMedGoogle Scholar
• Monroe JG. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol. 2006 Apr;6(4):283–294. PubMed PMID: 16557260.
   PubMed Web of Science ®Google Scholar
• Juszczynski P, Chen L, O’Donnell E, et al. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt. Blood. 2009 Dec 17;114(26):5315–5321. PubMed PMID: 19855081; PubMed Central PMCID: PMCPMC2796136.
   PubMed Web of Science ®Google Scholar
• Spady DK. Lipoproteins in biological fluids and compartments: synthesis, interconversions, and catabolism. Lipoproteins as Carriers of Pharmacological Agents, J.M. Shaw. Marcel Dekker, New York 1991;5:1–44. PubMed PMID: 1797165.
   Google Scholar
• Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):431–438. PubMed PMID: 19299327; PubMed Central PMCID: PMCPMC2740366.
   PubMed Web of Science ®Google Scholar
• Pirillo A, Catapano AL, Norata GD. Biological consequences of dysfunctional HDL. Curr Med Chem. 2018 May 29. PubMed PMID: 29848265. DOI:10.2174/0929867325666180530110543.
   PubMed Web of Science ®Google Scholar
• Trigatti BL. SR-B1 and PDZK1: partners in HDL regulation. Curr Opin Lipidol. 2017 Apr;28(2):201–208. PubMed PMID: 28134663. .
   PubMed Web of Science ®Google Scholar
• Mooberry LK, Sabnis NA, Panchoo M, et al. Targeting the SR-B1 receptor as a gateway for cancer therapy and imaging. Front Pharmacol. 2016 Dec;15(7):ARTN 466. PubMed PMID: WOS:000389742900001; English.
   Web of Science ®Google Scholar
• Li J, Wang J, Li M, et al. Up-regulated expression of scavenger receptor class B type 1 (SR-B1) is associated with malignant behaviors and poor prognosis of breast cancer. Pathol Res Pract. 2016 Jun 01;212(6):555–559. .
   PubMed Web of Science ®Google Scholar
• Ganjali S, Ricciuti B, Pirro M, et al. High-density lipoprotein components and functionality in cancer: state-of-the-art. Trends Endocrinol Metab. 2019 Jan;30(1):12–24. PubMed PMID: 30473465.
   PubMed Web of Science ®Google Scholar
• Plebanek MP, Bhaumik D, Thaxton CS. HDL and the golden key to cancer immunity? Oncoscience. 2018 May;5(5–6):164–166. PubMed PMID: 30035178; PubMed Central PMCID: PMCPMC6049305.
   PubMedGoogle Scholar
• Vanpouille-Box C, Diamond JM, Pilones KA, et al. TGF beta is a master regulator of radiation therapy-induced antitumor immunity. Cancer Res. 2015 Jun 1;75(11):2232–2242. PubMed PMID: WOS:000357333500012; English.
   PubMed Web of Science ®Google Scholar
• Kumar V, Patel S, Tcyganov E, et al. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 2016 Mar;37(3):208–220. PubMed PMID: 26858199; PubMed Central PMCID: PMCPMC4775398.
   PubMed Web of Science ®Google Scholar
• Plebanek MP, Bhaumik D, Bryce PJ, et al. Scavenger receptor type B1 and lipoprotein nanoparticle inhibit myeloid derived suppressor cells. 2017 Dec 27. en. doi: 10.1158/1535-7163.MCT-17-0981.
   Google Scholar
• Yvan-Charvet L, Pagler T, Gautier EL, et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science. 2010 Jun 25;328(5986):1689–1693. PubMed PMID: 20488992; PubMed Central PMCID: PMCPMC3032591.
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):139–143. PubMed PMID: 19797709; PubMed Central PMCID: PMCPMC2812788.
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN, Heinecke JW. Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins. J Lipid Res. 2009 Oct;50(10):1967–1975. PubMed PMID: WOS:000269985100002; English.
   PubMed Web of Science ®Google Scholar
• Mazidi M, Mikhailidis DP, Banach M. Associations between risk of overall mortality, cause-specific mortality and level of inflammatory factors with extremely low and high high-density lipoprotein cholesterol levels among American adults. Int J Cardiol. 2019 Feb 1;276:242–247. PubMed PMID: 30473336.
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG, Madsen CM, Varbo A. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Atherosclerosis. 2017 Aug;263:E89–E89. PubMed PMID: WOS:000407634000258; English.
   Web of Science ®Google Scholar
• Scanu A. Binding of human serum high density lipoprotein apoprotein with aqueous dispersions of phospholipids. J Biol Chem. 1967 Feb 25;242(4):711–719. PubMed PMID: 6017739.
   PubMed Web of Science ®Google Scholar
• Denisov IG, Grinkova YV, Lazarides AA, et al. Directed self-assembly of monodisperse phospholipid bilayer Nanodiscs with controlled size. J Am Chem Soc. 2004 Mar 24;126(11):3477–3487. PubMed PMID: 15025475.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Imura T, Leman LJ, et al. Mimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructs. J Am Chem Soc. 2013 Sep 11;135(36):13414–13424. PubMed PMID: 23978057; PubMed Central PMCID: PMCPMC3839580.
   PubMed Web of Science ®Google Scholar
• Mooberry LK, Nair M, Paranjape S, et al. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier. J Drug Target. 2010 Jan;18(1):53–58. PubMed PMID: 19637935.
   PubMed Web of Science ®Google Scholar
• Thaxton CS, Daniel WL, Giljohann DA, et al. Templated spherical high density lipoprotein nanoparticles. rapid-communication. 2009 Jan 9. EN. DOI: 10.1021/ja808856z.
   Google Scholar
• Luthi AJ, Lyssenko NN, Quach D, et al. Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein. J Lipid Res. 2015 May;56(5):972–985. PubMed PMID: 25652088; PubMed Central PMCID: PMCPMC4409287.
   PubMed Web of Science ®Google Scholar
• Cormode DP, Skajaa T, van Schooneveld MM, et al. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett. 2008 Nov;8(11):3715–3723. PubMed PMID: 18939808; PubMed Central PMCID: PMCPMC2629801.
   PubMed Web of Science ®Google Scholar
• Redmond KA, Nguyen TS, Ryan RO. All-trans-retinoic acid nanodisks. Int J Pharm. 2007 Jul 18;339(1–2):246–250. PubMed PMID: WOS:000248391700030; English.
   PubMedGoogle Scholar
• Singh ATK, Ghosh M, Forte TM, et al. Curcumin nanodisk-induced apoptosis in mantle cell lymphoma. Leukemia Lymphoma. 2011 Aug;52(8):1537–1543. PubMed PMID: WOS:000292747300020; English.
   PubMed Web of Science ®Google Scholar
• Burgess BL, He YM, Baker MM, et al. NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency. Int J Nanomedicine. 2013;8:4733–4742. PubMed PMID: WOS:000328197100001; English.
   PubMed Web of Science ®Google Scholar
• McMahon KM, Mutharasan RK, Tripathy S, et al. Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. [ rapid-communication]. Nano Letters. 2011 Feb 14. EN. DOI:10.1021/nl1041947.
   PubMed Web of Science ®Google Scholar
• Yang M, Jin HL, Chen JA, et al. Efficient cytosolic delivery of siRNA Using HDL-Mimicking nanoparticles. Small. 2011 Mar 7;7(5):568–573. PubMed PMID: WOS:000288081900003; English.
   PubMed Web of Science ®Google Scholar
• McMahon KM, Plebanek MP, Thaxton CS. Properties of native high-density lipoproteins inspire synthesis of actively targeted in vivo siRNA delivery vehicles. Adv Funct Mater. 2016 Nov 15;26(43):7824–7835. PubMed PMID: 28717350; PubMed Central PMCID: PMCPMC5510894.
   PubMed Web of Science ®Google Scholar
• Ghosh M, Ren G, Simonsen JB, et al. Cationic lipid nanodisks as an siRNA delivery vehicle. Biochem Cell Biol. 2014 Jun;92(3):200–205. PubMed PMID: WOS:000346365700005; English.
   PubMedGoogle Scholar
• Simonsen JB. Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications. Nanomedicine. 2016 Oct;12(7):2161–2179. PubMed PMID: 27237620. .
   PubMed Web of Science ®Google Scholar
• Low H, Hoang A, Sviridov D. Cholesterol efflux assay. J Vis Exp. 2012 Mar 6;61:e3810. PubMed PMID: 22414908; PubMed Central PMCID: PMCPMC3460567.
   Google Scholar
• Kuai R, Li D, Chen YE, et al. High-density lipoproteins: nature’s multifunctional nanoparticles. Acs Nano. 2016 Mar;10(3):3015–3041. PubMed PMID: WOS:000372855400004; English.
   PubMed Web of Science ®Google Scholar
• Keyserling CH, Barbaras R, Benghozi R, et al. Development of CER-001: preclinical dose selection through to Phase I clinical findings. Clin Drug Investig. 2017 May;37(5):483–491. PubMed PMID: 28213743; PubMed Central PMCID: PMCPMC5394142.
   PubMed Web of Science ®Google Scholar
• Andrews J, Janssan A, Nguyen T, et al. Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study. Cardiovasc Diagn Ther. 2017 Feb;7(1):45–51. PubMed PMID: 28164012; PubMed Central PMCID: PMCPMC5253449.
   PubMed Web of Science ®Google Scholar
• Easton R, Gille A, D’Andrea D, et al. A multiple ascending dose study of CSL112, an infused formulation of ApoA-I. J Clin Pharmacol. 2014 Mar;54(3):301–310. PubMed PMID: WOS:000331260100009; English.
   PubMed Web of Science ®Google Scholar
• Choi HS, Liu W, Misra P, et al. Renal clearance of quantum dots. Nat Biotechnol. 2007 Oct;25(10):1165–1170. PubMed PMID: WOS:000250226600028; English.
   PubMed Web of Science ®Google Scholar
• Yang H, Fogo AB, Kon V. Kidneys: key modulators of high-density lipoprotein levels and function. Curr Opin Nephrol Hypertens. 2016 May;25(3):174–179. PubMed PMID: 27008596; PubMed Central PMCID: PMCPMC4899840. .
   PubMed Web of Science ®Google Scholar
• Yetukuri L, Söderlund S, Koivuniemi A, et al. Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol. en. 2010 Aug 01. DOI:10.1194/jlr.M006494
   Google Scholar
• Li D, Fawaz MV, Morin EE, et al. effect of synthetic high density lipoproteins modification with polyethylene glycol on pharmacokinetics and pharmacodynamics. Mol Pharm. 2018 Jan 2;15(1):83–96. PubMed PMID: 29141139.
   PubMedGoogle Scholar
• Murphy AJ, Funt S, Gorman D, et al. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity. Circ Res. 2013 Jun 21;113(1):e1–e9. PubMed PMID: 23613182; PubMed Central PMCID: PMCPMC3905798.
   PubMed Web of Science ®Google Scholar
• Tang J, Kuai R, Yuan W, et al. Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting. Nanomedicine. 2017 Aug;13(6):1869–1878. PubMed PMID: 28434931; PubMed Central PMCID: PMCPMC5554706.
   PubMed Web of Science ®Google Scholar
• Verhoef JJ, Carpenter JF, Anchordoquy TJ, et al. Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discov Today. 2014 Dec;19(12):1945–1952. PubMed PMID: 25205349.
   PubMed Web of Science ®Google Scholar
• Verhoef JJF, Anchordoquy TJ. Questioning the use of PEGylation for drug delivery. [ Drug Deliv Transl Re]. Drug Delivery Transl Res. 2013 Dec 3; (6)499–503. PubMed PMID: WOS:000209424800001; English. DOI:10.1007/s13346-013-0176-5.
   PubMed Web of Science ®Google Scholar
• Yuan B, Wu C, Wang X, et al. High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer. Tumour Biol. 2016 Mar;37(3):3581–3588. PubMed PMID: 26456958.
   PubMedGoogle Scholar
• Johnson R, Sabnis N, Sun X, et al. SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer. Breast Cancer (Dove Med Press). 2017;9:383–392. PubMed PMID: 28670138; PubMed Central PMCID: PMCPMC5479299. .
   PubMed Web of Science ®Google Scholar
• Wang W, Chen K, Su Y, et al. Lysosome-independent intracellular drug/gene codelivery by lipoprotein-derived nanovector for synergistic apoptosis-inducing cancer-targeted therapy. [ research-article]. Biomacromolecules. 2018 Jan 24;19:438–448. EN.
   Web of Science ®Google Scholar
• Kuai R, Subramanian C, White PT, et al. Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma. Int J Nanomedicine. 2017;12:6581–6594. PubMed PMID: 28919755; PubMed Central PMCID: PMCPMC5593402. .
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang C, Ding Y, et al. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy. Colloids Surf B Biointerfaces. 2016 Dec;1(148):533–540. PubMed PMID: 27690242.
   PubMed Web of Science ®Google Scholar
• Tabet F, Vickers KC, Cuesta Torres LF, et al. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat Commun. 2014 Feb;28(5):3292. PubMed PMID: 24576947; PubMed Central PMCID: PMCPMC4189962.
   PubMed Web of Science ®Google Scholar
• Rui M, Tang H, Li Y, et al. Recombinant high density lipoprotein nanoparticles for target-specific delivery of siRNA. Pharm Res. 2013 May;30(5):1203–1214. PubMed PMID: 23242841.
   PubMed Web of Science ®Google Scholar
• Ding Y, Wang Y, Zhou J, et al. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis. Biomaterials. 2014 Aug 01;35(25):7214–7227.
   PubMed Web of Science ®Google Scholar
• Lin Q, Chen J, Ng KK, et al. Imaging the cytosolic drug delivery mechanism of HDL-like nanoparticles. Pharm Res. 2014 Jun;31(6):1438–1449. PubMed PMID: 23625096.
   PubMed Web of Science ®Google Scholar
• Tripathy S, Vinokour E, McMahon KM, et al. High density lipoprotein nanoparticles deliver RNAi to endothelial cells to inhibit angiogenesis. Part Part Syst Charact. 2014 Nov 1;31(11):1141–1150. PubMed PMID: 25400330; PubMed Central PMCID: PMCPMC4228967.
   PubMed Web of Science ®Google Scholar
• Shahzad MMK, Mangala LS, Han HD, et al. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia. 2011 Apr;13(4):309–U142. PubMed PMID: WOS:000289529400002; English.
   PubMed Web of Science ®Google Scholar
• Li M, Su Y, Zhang F, et al. A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy. Acta Biomater. 2018 Jul 15; 75:413–426. PubMed PMID: 29859368.
   PubMed Web of Science ®Google Scholar
• Yang S, Damiano MG, Zhang H, et al. Biomimetic, synthetic HDL nanostructures for lymphoma. Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2511–2516. PubMed PMID: 23345442; PubMed Central PMCID: PMCPMC3574906. eng.
   PubMed Web of Science ®Google Scholar
• McMahon KM, Scielzo C, Angeloni NL, et al. Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia. Oncotarget. 2017 Feb 14;8(7):11219–11227. PubMed PMID: 28061439; PubMed Central PMCID: PMCPMC5355259.
   PubMedGoogle Scholar
• Cedo L, Garcia-Leon A, Baila-Rueda L, et al. ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer. Sci Rep. 2016 Nov;3(6):36387. PubMed PMID: 27808249; PubMed Central PMCID: PMCPMC5093413.
   PubMed Web of Science ®Google Scholar
• Plebanek MP, Mutharasan RK, Volpert O, et al. Nanoparticle targeting and cholesterol flux through scavenger receptor Type B-1 inhibits cellular exosome uptake. [ Research]. Sci Rep. 2015 Oct 29;5:15724. En.
   PubMed Web of Science ®Google Scholar
• Angeloni NL, McMahon KM, Swaminathan S, et al. Pathways for modulating exosome lipids identified by high-density lipoprotein-like nanoparticle binding to scavenger receptor Type B-1. [ Research]. Sci Rep. 2016 Mar 11;6:22915. En.
   PubMed Web of Science ®Google Scholar
• Peinado H, Alečković M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. [ Research]. Nat Med. 2012 May 27;18(6):883. En.
   PubMed Web of Science ®Google Scholar
• Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. [ Research]. Nat Cell Biol. 2015 May 18;17(6):816. En.
   PubMed Web of Science ®Google Scholar
• Exosomes released by K562 chronic myeloid leukemia cells promote angio. 2016. doi: 10.1007/s10456-011-9241-1.
   Google Scholar
• Greening D. Emerging roles of exosomes during epithelial–mesenchymal transition and cancer progression. Semin Cell Dev Biol. 2015 April;2015(40):60–71.
   Google Scholar
• Plebanek MP, Mutharasan RK, Volpert O, et al. Nanoparticle targeting and cholesterol flux through scavenger receptor Type B-1 inhibits cellular exosome uptake. Sci Rep. 2015 Oct;29(5):15724. PubMed PMID: 26511855; PubMed Central PMCID: PMCPMC4625174. eng.
   PubMed Web of Science ®Google Scholar
• Sag D, Cekic C, Wu R, et al. The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity. Nat Commun. 2015 Feb;27(6):6354. PubMed PMID: 25724068; PubMed Central PMCID: PMCPMC4347884.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay A, Grijalva V, Hough G, et al. Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer. Pharmacol Res Perspect. 2015 Aug;3(4):e00154. PubMed PMID: 26171234; PubMed Central PMCID: PMCPMC4492730.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay A, Yang X, Mukherjee P, et al. Treating the intestine with oral ApoA-I mimetic Tg6F reduces tumor burden in mouse models of metastatic lung cancer. Sci Rep. 2018 Jun 13;8(1):9032. PubMed PMID: 29899427; PubMed Central PMCID: PMCPMC5998131.
   PubMed Web of Science ®Google Scholar
• Peng M, Zhang Q, Cheng Y, et al. Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression. Oncotarget. 2017 Nov 21;8(59):99693–99706. PubMed PMID: 29245934; PubMed Central PMCID: PMCPMC5725125.
   PubMedGoogle Scholar
• Su F, Kozak KR, Imaizumi S, et al. Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19997–20002. PubMed PMID: 21041624; PubMed Central PMCID: PMCPMC2993420.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Liu Y, Jin H, et al. Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles. Theranostics. 2013 Jun 25;3(7):477–486. PubMed PMID: 23843895; PubMed Central PMCID: PMC3706691.
   Web of Science ®Google Scholar